Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 1, 2018.
Article Versions
- You are currently viewing a Latest version of this article (March 1, 2018 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2018 The Journal of Rheumatology
Author Information
- Julie E. Davidson,
- Qinggong Fu,
- Beulah Ji,
- Sapna Rao,
- David Roth,
- Laurence S. Magder and
- Michelle Petri
- From the Real World Evidence and Clinical Development, GlaxoSmithKline R&D, Stockley Park, Uxbridge, UK; GlaxoSmithKline R&D, Upper Providence, Pennsylvania, and Research Triangle Park, North Carolina; the Department of Epidemiology and Public Health, University of Maryland; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
This study was funded by GlaxoSmithKline (GSK). The Hopkins Lupus Cohort was funded by the US National Institutes of Health (AR 43727 and AR 69572). JED was a shareholder of GSK and an employee of GSK at the time of the study, and is a current employee of Eli Lilly and Company Ltd.
QF is a shareholder and an employee of GSK. BJ is a shareholder and an employee of GSK. SR is an employee of GSK. DR is a shareholder and an employee of GSK.
J.E. Davidson*, PhD, MPH, Real World Evidence, GlaxoSmithKline R&D; Q. Fu, PhD, Real World Evidence, GlaxoSmithKline R&D; B. Ji, MD, Clinical Development, GlaxoSmithKline R&D; S. Rao, MS, Real World Evidence, GlaxoSmithKline R&D; D. Roth, MD, Clinical Development, GlaxoSmithKline R&D; L.S. Magder, PhD, Department of Epidemiology and Public Health, University of Maryland; M. Petri, MD, Division of Rheumatology, Johns Hopkins University School of Medicine. *Name at the time of the study.
Address correspondence to Dr. B. Ji, GSK, Stockley Park West, 1-3 Ironbridge Road, Uxbridge, Middlesex UB11 1BT, UK. E-mail: Beulah.N.Ji@gsk.com.
Full Release Article. For details see Reprints/Permissions at jrheum.org.
Accepted for publication November 28, 2017.